Xtant Medical Holdings, Inc.XTNTNYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank79
3Y CAGR-16.8%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-16.8%/yr
Quarterly compound
Percentile
P79
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 3.88% |
| Q2 2025 | 13.92% |
| Q1 2025 | -1.14% |
| Q4 2024 | -8.66% |
| Q3 2024 | -2.03% |
| Q2 2024 | -5.66% |
| Q1 2024 | -7.27% |
| Q4 2023 | -7.45% |
| Q3 2023 | 50.10% |
| Q2 2023 | -5.36% |
| Q1 2023 | -4.76% |
| Q4 2022 | -10.23% |
| Q3 2022 | 6.74% |
| Q2 2022 | -1.99% |
| Q1 2022 | -5.36% |
| Q4 2021 | -5.66% |
| Q3 2021 | -3.74% |
| Q2 2021 | -4.84% |
| Q1 2021 | -40.96% |
| Q4 2020 | 119.18% |
| Q3 2020 | -0.36% |
| Q2 2020 | -2.01% |
| Q1 2020 | -6.24% |
| Q4 2019 | -2.39% |
| Q3 2019 | -2.48% |
| Q2 2019 | -6.83% |
| Q1 2019 | 10.58% |
| Q4 2018 | -445.34% |
| Q3 2018 | 22.52% |
| Q2 2018 | -62.32% |
| Q1 2018 | 105.37% |
| Q4 2017 | -94.59% |
| Q3 2017 | -41.34% |
| Q2 2017 | -80.81% |
| Q1 2017 | -33.26% |
| Q4 2016 | -28.45% |
| Q3 2016 | -919.51% |
| Q2 2016 | -113.20% |
| Q1 2016 | -58.39% |
| Q4 2015 | 375.11% |